Raised status of domestic anticancer drugs

‘Supect(radotinib)’ developed by Ilyang Pharmaceutical emerged in the leukemia treatment market which used to be occupied only by multinational companies. Anticancer treatments are no longer multinational companies’ exclusive products.

Although a SK Chemicals’ stomach cancer treatment, ‘Sunpla Inj,’ a Dong Wha Pharm’s liver cancer treatment, ‘Milican Inj’ and Chong Kun Dang’s ‘Camtobell Inj’ h...